1.
J Med Chem
; 46(3): 349-52, 2003 Jan 30.
Artículo
en Inglés
| MEDLINE
| ID: mdl-12540232
RESUMEN
Imidazo[1,2-a]pyridyl N-arylpyridazinones were hybridized from the classic pyridinylimidazoles and the more recent dual hydrogen bond acceptors, resulting in a new structural class of selective p38 MAP kinase inhibitors.